Minakem-flap
Minakem-flap

Market Place

Market Place

Menu

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Prices
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry

    Find Clinical Drug Development Pipelines & Deals | PipelineProspector

    Loading...

    All Data

    Filters Filter refresh
    ×
    FILTER DATA :
    News Type filter
      Company filter
        Product Type filter
          Deal Size filter
            Upfront Payment filter
              refresh

              Product Type Full Screen

              Companies Full Screen

              Bavarian Nordic

              • Deals

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              DENMARK Denmark

              Post An Enquiry Post An Enquiry

              Virtual Booth Virtual Booth

              CPhI Discover 2021

              Participation Not Confirmed

              Update your events

              Bavarian Nordic to Manufacture Additional Ebola Vaccines for Janssen

              Contact the Supplier

              Lead Product(s): MVA-BN Filo vaccine

              Therapeutic Area: Infections and Infectious Diseases Product Name: MVA-BN-Filo

              Highest Development Status: Phase III Product Type: Vaccine

              Partner/Sponsor/Collaborator: Janssen Pharmaceutical

              Deal Size: $13.9 million Upfront Cash: Undisclosed

              Deal Type: Agreement June 18, 2020

              Details:

              Bavarian Nordic will manufacture and deliver bulk drug substance of its MVA-BN Filo vaccine, which Janssen has licensed as part of its Ebola vaccine regimen.

              PharmaCompass__DigitalAd